newlogo presentation
TRANSCRIPT
![Page 1: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/1.jpg)
Drug TreatmentDrug Treatment
andand
PrescribingPrescribing
Vincent HesseyVincent Hessey
![Page 2: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/2.jpg)
DANOS UNITSAA3, AC1, AC3, AD1, AD4
• Understand the impact of substance misuse in the locality.
• Be aware of services commissioned to respond to the above.
• Understand how the service operates strategically and on a day to day basis.
• Understand how to access the service and treatments available.
![Page 3: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/3.jpg)
![Page 4: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/4.jpg)
WALLASEY
BIRKENHEAD
WEST WIRRAL
Wirral MapWirral Map
![Page 5: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/5.jpg)
WIRRAL DRUG SERVICE WIRRAL POPULATION circa 312,293 (census 2001)WIRRAL POPULATION circa 312,293 (census 2001) HEROIN ‘EPIDEMIC DURING’ 1980’sHEROIN ‘EPIDEMIC DURING’ 1980’s 4475 DRUG USERS = 2.3 % of total population *4475 DRUG USERS = 2.3 % of total population * WIRRAL HIV/AIDS PREVENTION UNIT( 1988)WIRRAL HIV/AIDS PREVENTION UNIT( 1988) WIRRAL DRUG SERVICE (1991)WIRRAL DRUG SERVICE (1991) CLIENTS IN TREATMENT 1500 (0.51% pop)CLIENTS IN TREATMENT 1500 (0.51% pop)
* 15-64 years population 195,566 source Centre for Public Health LJMU May 2003 > Ratio ( 1in) 1-43
![Page 6: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/6.jpg)
MISSION STATEMENTWIRRAL DRUG SERVICE PROVIDES QUALITY ACCESSIBLE WIRRAL DRUG SERVICE PROVIDES QUALITY ACCESSIBLE
INTERVENTIONS FOR THOSE WHOSE LIVES ARE INTERVENTIONS FOR THOSE WHOSE LIVES ARE AFFECTED AFFECTED
BY DRUG USE, TREATING THEM WITH DIGNITY AND BY DRUG USE, TREATING THEM WITH DIGNITY AND RESPECT. RESPECT.
THE SERVICE RESPONDS TO THE DIVERSITY OF THE THE SERVICE RESPONDS TO THE DIVERSITY OF THE COMMUNITY COMMUNITY
AND RECOGNISES THE NEEDS OF INDIVIDUAL CLIENTS, AND RECOGNISES THE NEEDS OF INDIVIDUAL CLIENTS, THEIR THEIR
FAMILIES AND CARERS. FAMILIES AND CARERS.
![Page 7: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/7.jpg)
NTA MID YEAR REVIEW MEETING
A more recent piece of research focussing on drug treatment from a drug users perspective, commissioned by the DAAT, has further confirmed that as far as substitute prescribing is concerned, Wirral’s drug treatment system is probably as good as it gets. That is not to say however, that things should remain as they are indefinitely.
Prescribing lies at the heart of any drug treatment system and will continue to remain so as described in the Governments New Drug Strategy; the prescribing system delivered across the Wirral and in particular by the Cheshire and Wirral NHS Foundation Trust, remains one of the most pragmatic, flexible and humane regimes we have encountered.
![Page 8: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/8.jpg)
The NTA look forward to assisting Wirral's drug treatment system to evolve over the future lifetime of this new drug strategy and we expect it to remain one of the most effective drug treatment systems the NTA currently oversees
Wirral continues to be one of our best performers and probably represents the very best approach to tackling drug misuse that the Governments last Drug Treatment Strategy aspired to. The New Drug Strategy will certainly mean change and evolution for Wirral's drug treatment system but we remain assured and confident that it is already responding to the challenge that the new drug strategy represents.
MARK HARRISNW DEPUTY REGIONAL MANAGERNATIONAL TREATMENT AGENCY
![Page 9: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/9.jpg)
HOSPITALREFERRAL
GPREFERRAL
SHARED CARE&
RECOVERYTEAM
TRIAGEASSESSMENT
REVIEW S
THEREVIEW
TEAM
CRIMINAL JUSTICESOCIAL CARE
HOSTELSPD CASELOAD
HARMREDUCTIO N
TEAMR
DUAL DIAGNOSISPSYCHOLOGIST
COMPLEX CLIENTSYOUNG PEOPLE
THEPROJECTS
TEAM
FULLDRUG
ASSESSMENT
SELFREFERRAL
OTHERAGENCY
W IRRALDRUG
SERVICE
DRUG PATHWAYDRUG PATHWAY
TreatmentExit
Team
OTCDual Diagnosis
PD CaseloadPsychologist
4 YO
Criminal JusticeHostels
Young PeopleSocial Care
![Page 10: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/10.jpg)
ASSESSMENT REASONS FOR PRESENTATIONREASONS FOR PRESENTATION DRUG HISTORY (PAST & PRESENT)DRUG HISTORY (PAST & PRESENT) HISTORY OF INJECTING (HIV, HEP C)HISTORY OF INJECTING (HIV, HEP C) MEDICAL HISTORYMEDICAL HISTORY PSYCHIATRIC HISTORYPSYCHIATRIC HISTORY FORENSIC HISTORY FORENSIC HISTORY SOCIAL HISTORYSOCIAL HISTORY PAST CONTACT WITH SERVICES PAST CONTACT WITH SERVICES URINALYSISURINALYSIS OTHER INFORMATIONOTHER INFORMATION
![Page 11: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/11.jpg)
ASSESSMENT
EXAMINATION MOTIVATIONMOTIVATION GENERAL HEALTHGENERAL HEALTH MENTAL HEALTHMENTAL HEALTH
SOCIAL CIRCUMSTANCESSOCIAL CIRCUMSTANCES FAMILY ISSUESFAMILY ISSUES HOUSING / HOMELESS PROBLEMSHOUSING / HOMELESS PROBLEMS(DRUGS MISUSE and DEPENDENCE - CLINICAL GUIDELINES)
![Page 12: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/12.jpg)
REASONS FOR PRESCRIBING IMPROVE CLIENTS HEALTHIMPROVE CLIENTS HEALTH REDUCE DRUG USE ( ILLICIT & PX)REDUCE DRUG USE ( ILLICIT & PX) ADDRESS DRUG RELATED PROBLEMSADDRESS DRUG RELATED PROBLEMS REDUCE DRUG RELATED HARM / DEATHSREDUCE DRUG RELATED HARM / DEATHS REDUCE DURATION OF DRUG USE EPISODESREDUCE DURATION OF DRUG USE EPISODES REDUCE CHANCE OF FUTURE RELAPSEREDUCE CHANCE OF FUTURE RELAPSE REDUCE NEED FOR CRIMINAL ACTIVITY REDUCE NEED FOR CRIMINAL ACTIVITY REDUCE RISK OF PRESCRIBED DRUGSREDUCE RISK OF PRESCRIBED DRUGS BEING SOLD ILLEGALLY BEING SOLD ILLEGALLY
![Page 13: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/13.jpg)
ASSESSING MOTIVATION
Rather than testing whether the applicant Rather than testing whether the applicant “really” wants to change, clinicians should “really” wants to change, clinicians should welcome the opportunity to demonstrate to welcome the opportunity to demonstrate to clients the benefits of treatment. The challenge clients the benefits of treatment. The challenge in drug treatment should not be to test in drug treatment should not be to test motivation, but to foster it, and to maximise the motivation, but to foster it, and to maximise the likelihood that the individual will benefit from likelihood that the individual will benefit from treatment.treatment. KEY ISSUES IN METHADONE MAINTENANCE TREATMENT
JEFF WARD, RICHARD MATTICK, WAYNE HALL
![Page 14: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/14.jpg)
METHODS OF PRESCRIBING METHADONE MIXTURE 1mg/1ml, 10mg/1mlETHADONE MIXTURE 1mg/1ml, 10mg/1ml METHADONE REEFERS 30mg, 60mg.METHADONE REEFERS 30mg, 60mg. METHADONE AMPOULES 50, 35, 20, 10 mgMETHADONE AMPOULES 50, 35, 20, 10 mg METHADONE TABLETS 5mgMETHADONE TABLETS 5mg DIAMORPHINE AMPOULES / REEFERSDIAMORPHINE AMPOULES / REEFERS BUPRENORPHINE (SUBUTEX)BUPRENORPHINE (SUBUTEX) BENZODIAZEPINESBENZODIAZEPINES ANTIDEPRESSANTS / ANTIPSYCHOTICSANTIDEPRESSANTS / ANTIPSYCHOTICS LOFEXEDINE / NALTREXONELOFEXEDINE / NALTREXONE
![Page 15: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/15.jpg)
WHAT TO PRESCRIBE
ASCERTAIN ILLICIT DRUG USEASCERTAIN ILLICIT DRUG USE INITIAL DOSAGE (30 mg)INITIAL DOSAGE (30 mg) SUPERVISED CONSUMPTIONSUPERVISED CONSUMPTION ORAL METHADONEORAL METHADONE DAILY PICK UPDAILY PICK UP TITRATE DOSAGETITRATE DOSAGE REVIEW REVIEW
![Page 16: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/16.jpg)
POLICIES AND PROCEDURES
MISUSE of DRUGS ACT 1971MISUSE of DRUGS ACT 1971 CHILDREN ACT 1989/2004CHILDREN ACT 1989/2004 TACKLING DRUGS (Government Strategy)TACKLING DRUGS (Government Strategy) NATIONAL TREATMENT AGENCYNATIONAL TREATMENT AGENCY MODELS OF CARE MODELS OF CARE CLINICAL GOVERNANCE (PRCISE)CLINICAL GOVERNANCE (PRCISE) DANOS DANOS QUADSQUADS
![Page 17: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/17.jpg)
REVIEW KEYWORKER /CLIENT - 3/12KEYWORKER /CLIENT - 3/12 ASSESS DRUG USEASSESS DRUG USE ASSESS CURRENT MEDICATIONASSESS CURRENT MEDICATION REVIEW HEALTH / MENTAL HEALTHREVIEW HEALTH / MENTAL HEALTH SOCIAL CIRCUMSTANCES / PROBLEMSSOCIAL CIRCUMSTANCES / PROBLEMS CHILD PROTECTION ISSUESCHILD PROTECTION ISSUES FORENSICFORENSIC EMPLOYMENT STATUSEMPLOYMENT STATUS CLIENT MOTIVATIONCLIENT MOTIVATION CARE PLAN/ RISK ASSESSMENT/ URINECARE PLAN/ RISK ASSESSMENT/ URINE
![Page 18: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/18.jpg)
DOCTORS REVIEW DOCTORS REVIEW 6/12DOCTORS REVIEW 6/12 ASSESS CURRENT PRESCRIPTION ASSESS CURRENT PRESCRIPTION ASCERTAIN CURRENT DRUG USEASCERTAIN CURRENT DRUG USE ADDRESS HEALTH / MENTAL HEALTHADDRESS HEALTH / MENTAL HEALTH REFER TO OTHER SERVICESREFER TO OTHER SERVICES CARE PATHWAY APPROACHCARE PATHWAY APPROACH INCREASE / DECREASE SCRIPTSINCREASE / DECREASE SCRIPTS DISCUSS FUTURE PLANSDISCUSS FUTURE PLANS
![Page 19: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/19.jpg)
Trans-theoretical Model of Behaviour Change
Preparation stageI prepare to stop/reduce the amount of drugs I use
Action stageI stop using drugs
RelapseI start to use drugs again
Maintenance / RecoveryI continue not to use drugs
PrecontemplationI believe there is no link between drugs and my health
ContemplationI perceive a link between my drug use and my health
Prochaska and DiClemente’s Wheel of Change (1991)
![Page 20: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/20.jpg)
Precontemplation -- Where there is no intention to change behaviour in the foreseeable future .
Contemplation -- Where there is awareness that a problem exists and one is seriously thinking about overcoming it but has not yet made a
commitment to take action.
Preparation -- Where the person is intending to take action soon and may have already unsuccessfully taken action during the past year.
Action -- Where the person modifies the behaviour, putting in a considerable amount of time
and energy, which is obvious to others.
Maintenance -- Where the person works to prevent relapse and consolidates the gains of the action
stage. This stage may go on for a long time, possibly a lifetime.
![Page 21: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/21.jpg)
REVIEW TEAMSREVIEW TEAMS
• 400 CLIENTS• 8 WORKERS• ENGAGEMENT /OUTREACH WORKERS• REVIEW CASELOADS• DIAMORPHINE TREATMENT
![Page 22: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/22.jpg)
PROJECTS TEAM
• 275 CLIENTS
• CRIMINAL JUSTICE PRACTITIONER
• HOSTELS/HOMELESS & YOUNG PERSONS LINK WORKER
• SOCIAL CARE CASELOAD / CO-ORDINATOR
• SUBSTANCE MISUSE WORKER
![Page 23: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/23.jpg)
PROJECTS TEAMDUAL DIAGNOSIS / MENTAL HEALTH NURSE
CLINICAL PSYCHOLOGIST(PERSONALITY DISORDERS)
4 YEARS + CLIENTS (4YO)
SUBSTANCE MISUSE PRACTITIONER (PERSONALITY DISORDERS)
OVER THE COUNTER PRACTITIONER
![Page 24: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/24.jpg)
HARM REDUCTION CENTREHARM REDUCTION CENTRE• NURSE LED SERVICE• NURSE PRESCRIBING• HEP C PATHWAY NURSE• HOMELESS NURSE PRACTITIONER• SYRINGE EXCHANGE• CONFIDENTIAL TESTING• SEXUAL HEALTH CLINIC• STEROID CLINIC• STIMULANT NURSE• WOMENS SERVICES• ALCOHOL NURSE PRACTITIONER• PHARMACY LIAISON WORKER
WIRRAL DRUG SERVICE
![Page 25: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/25.jpg)
SHARED CARE & RECOVERY TEAMSHARED CARE & RECOVERY TEAM
• 16 WORKERS• 780 CLIENTS (700/80)• 100% WIRRAL GP’S• GP TRAINING• RCGP ACCREDITATION
WIRRAL DRUG SERVICE
![Page 26: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/26.jpg)
SHARED CARE & RECOVERY TEAMSHARED CARE & RECOVERY TEAM
• VARIETY OF PRESCRIBING OPTIONS• ALTERNATIVE THERAPIES• DETOX TRANSITION• RECOVERY PROGRAMMES• REFER TO AFTERCARE
![Page 27: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/27.jpg)
Treatment Exit Team
• Stable Clients• Reducing off Script• Regular Contact• Therapeutic Interventions• Prepared to exit within 3-6 months as
drug free
![Page 28: Newlogo presentation](https://reader033.vdocument.in/reader033/viewer/2022052900/555ea874d8b42a902e8b4bdf/html5/thumbnails/28.jpg)
REFERENCES & LINKSDRUGS MISUSE and DEPENDENCE - CLINICAL GUIDELINES
DOH PUBLICATION
TACKLING DRUGS TO BUILD A BETTER BRITAIN (1998)
WWW.WIRRALDRUGSERVICE.ORG
METHADONE BRIEFING (ANDREW PRESTON)
KEY ISSUES IN METHADONE MAINTENANCE TREATMENT
( JEFF WARD, RICHARD MATTICK, WAYNE HALL )
Applications to Addictive Behaviours, (James 0. Prochaska, Carlo C. DiClemente and John C. Norcross) (pp. 1102-1114 Vol. 47, No. 9), (1991)
FIRST INTERNATIONAL CONFERENCE ON HARM REDUCTION
(Newcombe,1991)
INSTITUTE FOR STUDY OF DRUG DEPENDENCE (1996)